Literature DB >> 30156674

Cultural adaptation and validation of the Brazilian Version of the Patient Activation Measure-22 items.

Cristiane Martins Cunha1, Eliane Nepomuceno1, Rafaela de Oliveira Manzato1, Débora Cristine Prévide Teixeira da Cunha1, Dirceu da Silva2, Rosana Aparecida Spadoti Dantas1.   

Abstract

OBJECTIVE: To adapt and validate the Patient Activation Measure (PAM22) in a sample of Brazilians with chronic diseases under outpatient monitoring.
METHOD: Adaptation process comprises translation, back translation, analysis by a committee of judges, semantic analysis, and pre-test. Psychometric validation was performed with 513 individuals. Construct validity was analyzed through Pearson's correlation, Student's t-test and Structural Equation Modeling; reliability was assessed by the intraclass correlation coefficient and Cronbach's Alpha.
RESULTS: The internal consistency was adequate and test-retest reliability was low to moderate (p < 0.05). Validity evidence was found on the convergent construct, with statistically significant correlations between measures of activation, self-esteem, anxiety, depression, and health status. The one-dimensionality of the theoretical model was not confirmed in the adapted version.
CONCLUSION: Results have shown that the adapted version is reliable and valid, although the theoretical model cannot be explained in a single dimension.

Entities:  

Mesh:

Year:  2018        PMID: 30156674     DOI: 10.1590/0034-7167-2016-0470

Source DB:  PubMed          Journal:  Rev Bras Enferm        ISSN: 0034-7167


  2 in total

1.  Validity and reliability of the Patient Activation Measure® (PAM®)-13 Malay version among patients with Metabolic Syndrome in primary care.

Authors:  N H Bahrom; A S Ramli; M R Isa; N Baharudin; S F Badlishah-Sham; M S Mohamed-Yassin; H Abdul-Hamid
Journal:  Malays Fam Physician       Date:  2020-11-10

2.  Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above.

Authors:  Zsombor Zrubka; Péter Vékás; Péter Németh; Ágota Dobos; Ottó Hajdu; Levente Kovács; László Gulácsi; Judith Hibbard; Márta Péntek
Journal:  Eur J Health Econ       Date:  2022-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.